Statin use would be expected to reduce the likelihood of observing an association between KIF6 719Arg and CHD because in 3 randomized studies[2], [5], statin therapy significantly reduced coronary events in KIF6 719Arg carriers but not in noncarriers. Here, KIF6 is linked to coronary artery disorder.